VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
-4.13%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$122M
AUM Growth
+$122M
(+15%)
Cap. Flow
+$27M
Cap. Flow
% of AUM
22.11%
Top 10 Holdings %
Top 10 Hldgs %
78.8%
Holding
34
New
4
Increased
4
Reduced
4
Closed
6
Top Buys
| 1 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$37M |
| 2 |
Inspire Medical Systems
INSP
|
$3.04M |
| 3 |
Heron Therapeutics
HRTX
|
$2.56M |
| 4 |
Gossamer Bio
GOSS
|
$2.55M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$1.9M |
Top Sells
| 1 |
ADMA Biologics
ADMA
|
$3.54M |
| 2 |
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
|
$3.12M |
| 3 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$3.11M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$2.17M |
| 5 |
89bio
ETNB
|
$1.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INBX
26
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $459K | 0.37% |
25,000
| – | – |
|
|
ELEV
27
DELISTED
Elevation Oncology
ELEV
| $330K | 0.27% |
497,299
| – | – |
|
28
AirSculpt Technologies
AIRS
$403M
| – | – |
0
| – | – |
|
|
AVDL
29
Avadel Pharmaceuticals
AVDL
$1.43B
| – | – |
-100,000
| Closed | -$1.65M |
|
|
30
89bio
ETNB
$1.34B
| – | – |
-95,000
| Closed | -$1.8M |
|
31
Iovance Biotherapeutics
IOVA
$807M
| – | – |
-240,000
| Closed | -$1.69M |
|
|
CTLT
32
DELISTED
CATALENT, INC.
CTLT
| – | – |
-50,000
| Closed | -$2.17M |
|
|
GRTX
33
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| – | – |
-1,000,000
| Closed | -$3.12M |
|
|
PNT
34
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| – | – |
-342,936
| Closed | -$3.11M |
|